World Hepatitis Day, hepatitis C can not be overlooked hazard
May 19, China will usher in the second “World Hepatitis Day.” “World Hepatitis Day” is the world’s hepatitis Union to arouse people’s concern about viral hepatitis prevention and treatment initiated. At present, viral hepatitis has become a threat to public health problems of all mankind, only hepatitis B, hepatitis C virus infection has been about 5 million people, accounting for almost the world’s number 1 / 12. In China, the number of patients with hepatitis B and hepatitis C more than 100 million persons. Because of the lack of hepatitis awareness, prevention and treatment properly, many patients adversely affected by the timing of the standard treatment, resulting in disease progression.
To raise public awareness of viral hepatitis and promote early treatment in patients with a firm confidence in patients, the Chinese Foundation for Hepatitis Prevention of World Hepatitis Day, the country will conduct “I have Hepatitis C Stories” sponsored events and series of hepatitis science educational activities. Recently, I contacted experts in the field of liver disease in Guangzhou, Professor: Professor Hou Jinlin Nanfang Hospital, Guangdong Provincial People’s Hospital, Professor Chen Wenli, Guangzhou and eight Deputy Dean Professor Yin Chibiao and Zhongshan Hospital 3 Professor Zhao Zhixin, detailed information about the situation, as well as the incidence of hepatitis C essay details, the following is an interview Record:
39 Health Net: invited experts to tell us about the Current Situation of China’s hepatitis C?
Expert: China Center for Disease Control and Prevention data show that infectious diseases reported in recent years, China’s report found the number of hepatitis C upward trend in 2008 about 12 million people in the last five years, turned around 5 times. Easy to develop chronic hepatitis C, about 75% ~ 85% of the hepatitis C virus infection may develop chronic hepatitis C infected with hepatitis C 20 years later, the annual incidence of cirrhosis was 10% ~ 15%, once the development of cirrhosis, liver cancer annual incidence of 1% ~ 7%. According to the National Sero-epidemiological survey data show that anti-HCV positive rate over a certain difference in the Yangtze River as the boundary, the North (3.6%) than in the South (2.9%), southwest, east, north, northwest, south-central and north-east, respectively 2.5%, 2.7%, 3.2%, 3.3%, 3.8% and 4.6% respectively. Anti-HCV positive rate increased gradually with age, from one age group to 2.0% from 50 to 59 age group to 3.9%. Was no significant difference between men and women. The positive rate of 300 ten-thousandth of Guangdong.
39 Health Net: invited experts to tell us about the symptoms of hepatitis C as well as the harm?
Expert: Patients infected with hepatitis C virus, the major clinical symptoms are not apparent. Only a few patients in the acute phase is usually mild symptoms or no symptoms. When it became chronic, many people in a very long time may not have any symptoms appear, (also a very small part of the chronic diseases in the chest or other parts of the Agency emerged spiders hemorrhoids) but the virus on the liver cell damage has been sustained with , until the liver becomes hardened or otherwise, may occur after liver cancer-related symptoms. Thus, HCV is considered the “silent killer.” Hepatitis C is a serious, chronic progressive disease, it is a continuous destruction of the liver. Because the initial symptoms was not obvious, they often are ignored, but the disease was unwittingly continued progress, if not timely diagnosis and treatment, which may develop into cirrhosis and liver cancer. Cirrhosis of the liver caused by hepatitis C liver disease has become one of the diseases in the highest fatality rate. Infected with hepatitis C virus, about 75% ~ 85% of patients with chronic hepatitis C evolution. And chronic hepatitis C, such as lack of timely, accurate, reasonable treatment, 10% ~ 30% may develop cirrhosis of the liver; hepatitis C patients with cirrhosis of the liver, about 3% to 10% can be turned into hepatocellular carcinoma. Hepatitis C can be seen on the health and labor productivity, great harm.
39 Health Net: What are the high risk of hepatitis C?
Expert: According to the Guangdong Provincial People’s Hospital, Professor Chen Wenli describes nine types of hepatitis C are mainly high-risk groups:
Prior to 1993 had received blood transfusions or blood products are; repeated dialysis and organ transplant recipients; sharing syringes were; HIV infected persons; babies born to mothers infected with HCV; acupuncture, stab wounds or damaged mucous membrane contact with HCV-positive blood Department persons; with HCV infection who have sex; had interventional treatment of patients (gastroscopy, endoscopy, dental equipment), there have been tattoos, Wen-mei, wearing earrings and other holes.
39 Health Net: treatment and prevention of hepatitis C What are the main?
Expert: with the hepatitis B virus can only control is difficult to cure different from the majority of hepatitis C is curable. But the key to early detection, early treatment, standard medication. Hepatitis C antibody (anti-HCV)-positive prompts are two possibilities: been or are being infected with HCV. For hepatitis C antibody (anti-HCV)-positive individuals, early diagnosis and prompt treatment is crucial. China’s “Guide to hepatitis C prevention and treatment,” says that if you take early antiviral treatment of hepatitis C, clear or sustained suppression of hepatitis C virus in vivo, we can improve or reduce the liver damage, to prevent the disease progressed to cirrhosis, liver failure and liver cancer . The first is the treatment of hepatitis C virus replication inhibition, thereby blocking hepatitis C virus on the liver to cirrhosis, liver cancer development process. Hepatitis C prevention and treatment in accordance with national guidelines, the current internationally recognized as the only effective treatment is interferon-α combined with ribavirin therapy. In order to further improve the efficacy, the U.S. and European guidelines on hepatitis C prevention and treatment with pegylated interferon replaced the ordinary interferon and ribavirin hepatitis C treatment to become the gold standard. Numerous large-scale clinical trial results show that pegylated interferon α-2a (Pegasys ®) combined with ribavirin treatment, Liu Cheng Qi Cheng patients are given access to effectively remove the virus and ultimately cure the disease.
Because hepatitis C vaccine still in the research stage, the current hepatitis C and prevention needs of society and individuals together to work. For the concerned sectors of society, to strengthen the blood products and medical devices regulation; For individuals, away from drug abuse, promiscuity and other bad behavior. Once suffering from hepatitis C, the most important is to get get rid of all alcoholic beverages, including: beer, liquor, wine and champagne, etc., and because hepatitis C is contagious, so patients with hepatitis C should avoid sharing razors and toothbrushes with others, such acts in order to avoid infecting others. In the physical examination, in addition to liver function tests, there should be hepatitis C virus antibody detection. Do hepatitis C early discovery, early diagnosis and early treatment.